FDA
Stay current with all the latest and breaking news about FDA, compare headlines and perspectives between news sources on stories happening today. In total, 1,678 stories have been published about FDA which Ground News has aggregated in the past 3 months.Stay current with all the latest and breaking news about FDA, compare headlines and perspectives between news sources on stories happening today. In total, 1,678 stories have been published about FDA which Ground News has aggregated in the past 3 months.
Covered Most By
Local News Publishers
No sources with tracked biases.
See less detail
Suggest a source
Looking for a source we don't already have? Suggest one here.Top FDA News
Latest News Stories
Woody AllenIn March 1998, the US FDA approved the blue pill. From cinema to music to political battle, an overwhelming costume success beyond...
From Woody Allen to Messina Denaro, history and anecdotes from 25 years of Viagra
100% Center coverage: 1 sources
CancerFDA proposes randomized controlled trials instead of widely used "single-arm studies" The agency's accelerated approval process has drawn fire for the way it allows manufacturers to launch products based on preliminary evidence and charge high prices before they complete trials. The comment period on the guidance runs through May 26.
FDA proposes overhaul of fast-track process for cancer meds
100% Left coverage: 1 sources
FDA · WashingtonU.S. health advisers on Wednesday were weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication to help fight the national opioid crisis.
FDA panel weighs moving opioid antidote over the counter
72% Center coverage: 96 sources
US & Canada · WashingtonDaniele International LLC, a Mapleville, R.I., establishment, is recalling approximately 52,914 pounds of ready-to-eat (RTE) sausage products. The products may be adulterated with Listeria monocytogenes. The RTE sausage products were produced on various dates from May 23, 2022, through November 25, 2022.
Recall Alert: Sausages Shipped Nationwide May Be Contaminated With Listeria
75% Center coverage: 66 sources
Business · MaharashtraThe Bombay High Court quashed the Maharashtra Food and Drug Administration’s orders cancelling Johnson and Johnson's license to manufacture its baby powder at Mulund factory. A division bench of Justice Gautam Patel and Justice SG Dhige said FDA's action was unreasonable and arbitrary. "An administrator cannot use a hammer to kill an ant," said the court.
Bombay HC permits Johnson & Johnson to manufacture and sell its baby powder
Coverage: 5 sources
AlzheimerJapanese drugmaker Eisai Co Ltd (4523.T) says it has submitted an application to the U.S. Food and Drug Administration for a standard review of its Alzheimer's drug Leqembi. The drug was recently approved under the agency's accelerated review process.
Eisai files for full FDA approval for Alzheimer's drug Leqembi
83% Right coverage: 6 sources
US & CanadaThe FDA has accepted a biologics license application for a long-acting antibody. If approved, it could be available for use in some infants and toddlers later this year. AstraZeneca and Sanofi, which developed the therapy, say the FDA "has indicated it will work to expedite its review"
FDA to review preventative option for RSV in infants, developers say
88% Center coverage: 17 sources
AlzheimerLecanemab is one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. It has shown "potential" as an Alzheimer's disease treatment, according to Phase 3 trial results. The FDA is expected to decide whether to grant accelerated approval to lecanemab by January 6.
FDA decision on experimental Alzheimer's drug expected this week
87% Center coverage: 30 sources
